VANCOUVER, BC -- (MARKET WIRE) -- August 31, 2006 -- Upstream Biosciences Inc. (OTCBB: UPBS) (“Upstream” or “the Company”), an emerging leader in the field of genetic diagnostics for cancer and the prediction of drug response, announced today the signing of a letter of engagement with Atlas Capital Services, LLC of New York (“Atlas”) to act as its investment banker. Atlas is a registered broker dealer and member of the NASD and Upstream will use their services in order to assist the Company in meeting the anticipated demand for its biomarker technologies.
